Publicacións (42) Publicacións nas que participase algún/ha investigador/a

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients

    EMBO Molecular Medicine

  3. Antiobesity effects of intestinal gluconeogenesis are mediated by the brown adipose tissue sympathetic nervous system

    Obesity, Vol. 32, Núm. 4, pp. 710-722

  4. Antioxidant micropeptins from a Microcoleus autumnalis-dominated benthic cyanobacterial mat from Western Ireland

    Phytochemistry, Vol. 223

  5. Application of a multi-toxin detect method to analyze mycotoxins occurrence in plant-based beverages

    Food Chemistry, Vol. 434

  6. Association between endocrine and neuropsychological endophenotypes and gambling disorder severity

    Addictive Behaviors, Vol. 153

  7. Bilateral Uveal Melanoma: An Insight into Genetic Predisposition in Four New Unrelated Patients and Review of Published Cases

    Journal of Clinical Medicine, Vol. 13, Núm. 11

  8. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  9. Ceramides in the central control of metabolism

    Trends in Endocrinology and Metabolism

  10. Cluster analysis in gambling disorder based on sociodemographic, neuropsychological, and neuroendocrine features regulating energy homeostasis

    Comprehensive Psychiatry, Vol. 128

  11. Correction to: Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits (Nature Reviews Endocrinology, (2024), 20, 4, (189-190), 10.1038/s41574-024-00955-3)

    Nature Reviews Endocrinology

  12. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  13. Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes

    DIABETES THERAPY

  14. Enniatins A1 and B1 Modulate Calcium Flux through Alternative Pathways beyond Mitochondria

    Journal of Agricultural and Food Chemistry, Vol. 72, Núm. 26, pp. 14975-14983

  15. Ferritin heavy chain supports stability and function of the regulatory T cell lineage

    EMBO Journal, Vol. 43, Núm. 8, pp. 1445-1483

  16. First description of adenosine production by Gnomoniopsis smithogilvyi, causal agent of chestnut brown rot

    World Journal of Microbiology and Biotechnology, Vol. 40, Núm. 5

  17. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

    Journal of Endocrinological Investigation, Vol. 47, Núm. 5, pp. 1139-1154

  18. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance

    Molecular Metabolism, Vol. 79

  19. Immunomodulatory leptin receptor+ sympathetic perineurial barrier cells protect against obesity by facilitating brown adipose tissue thermogenesis

    Immunity, Vol. 57, Núm. 1, pp. 141-152.e5

  20. Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe

    Endocrine, Vol. 83, Núm. 3, pp. 585-593